Could a traditional Plant-Based diet curb diabetes risk in latino communities?

NCT ID NCT05444595

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether a culturally tailored plant-based diet, guided by community health workers, can help Latino adults with obesity lose weight and improve metabolic health. Forty participants will be randomly assigned to either the plant-based diet program or standard health advice for 16 weeks. The goal is to see if this approach is both effective and acceptable in an underserved population at risk for diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral plant-based dietary intervention
What this could lead to
If effective, this culturally tailored diet program could offer a practical, low-cost way to reduce obesity and diabetes risk in underserved Latino communities.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The diet requires significant lifestyle changes, and long-term adherence is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Aug 2023

Expected to finish

Jan 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-reported Hispanic and/or Latino heritage * Body Mass Index (BMI) 30-42 kg/m² * HbA1c ≤ 6.4% Exclusion Criteria: * Previous diagnosis of diabetes * Unstable weight (≥4% during the last 2 months prior to study enrollment) * Severe cardiovascular disease within the 6 months prior to study enrollment * Severe organ system dysfunction * active substance abuse with alcohol or drugs * Severe anemia * Pregnant or breastfeeding * Use of medications that are known to affect the study outcome measures * Persons who are not able to grant voluntary informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sansum Diabetes Research Institute

    Santa Barbara, California, 93105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.